Alibaba Group Holding (NYSE:BABA), the Chinese e commerce operator behind Alibaba.com and AliExpress, has agreed to pay 600 million dollars to settle a Justice Department dispute over illegal pharmaceutical sales flowing through its U.S. payment platform.
Data as of 2026-06-28Price 96.14 USD Day change -1.85 (-1.89%) 52-week range 91.99 – 146.87 Market cap $230.70B Dividend yield 1.09% RSI (14) 24.03 Volume 11,764,187
What the Settlement Covers
The Justice Department accused AUS Merchant Services, the U.S. based payment processor tied to Alibaba, of failing to stop merchants from selling and importing banned pharmaceuticals, controlled substances, regulated chemicals and pill making equipment through Alibaba.com and AliExpress.com. Alibaba acknowledged in its agreement with prosecutors that between January 2016 and December 2024 it did not prevent roughly 80,000 product sales that violated the Federal Food, Drug, and Cosmetic Act and related statutes.
According to the government's release, some employees had flagged that internal compliance systems were not catching these transactions, and certain merchants reportedly steered buyers toward third party messaging apps to complete illegal deals outside Alibaba's own monitored channels. Investigators from the FDA, FDIC and IRS Criminal Investigation unit ran more than 40 undercover purchases of pharmaceuticals and manufacturing equipment before reaching the non prosecution agreement. IRS CI Chief Jarod Koopman said the outcome reflects his agency's effort to track financial flows and hold companies operating in the United States to federal compliance standards.
Alibaba Stock: Valuation, Momentum and Yield
Shares of Alibaba slid 1.89% to 96.14 dollars, sitting well below the stock's 52 week high of 146.87 and not far above its low of 91.99. The American depositary shares, each representing eight ordinary shares, now carry a market capitalization of 230.70 billion dollars. A Relative Strength Index reading of 24.03 puts the stock deep in oversold territory, a level traders often watch as a signal that selling pressure has outpaced the underlying fundamentals, though it carries no guarantee of a rebound.
The bull case rests on Alibaba's scale: e commerce platforms spanning multiple markets, a dividend yield of 1.09% that still returns cash to shareholders, and a valuation that has compressed sharply from its 52 week peak. Supporters argue the settlement removes a legal overhang that had clouded sentiment. The bear case centers on regulatory exposure that outlasts a single fine, questions about whether compliance gaps extend beyond payments into other parts of the platform, and a stock trending near its yearly lows even before this news broke.
How Wide Was the Compliance Gap
The scope described in the settlement, nearly a decade of unchecked sales and tens of thousands of flagged transactions, raises the question of how deep the enforcement failures ran inside Alibaba's U.S. facing operations. The non prosecution agreement resolves the specific claims tied to AUS Merchant Services, but it leaves open how the company plans to demonstrate durable fixes to the compliance controls that employees themselves had questioned.